Thor Medical ASA 

€0.43
29
+€0+0.23% Today

Statistics

Day High
0.43
Day Low
0.43
52W High
0.51
52W Low
0.19
Volume
-
Avg. Volume
-
Mkt Cap
151.63M
P/E Ratio
-
Dividend Yield
-
Dividend
-

Upcoming

Earnings

26FebExpected
Q3 2023
Q4 2023
Q1 2024
Q2 2024
Q4 2024
Q2 2025
Q4 2025
-0.1
-0.07
-0.03
0
Expected EPS
-0.09470582809999999
Actual EPS
N/A

Financials

-Profit Margin
Unprofitable
2019
2020
2021
2022
2023
2024
0Revenue
-7.27MNet Income

People Also Follow

This list is based on the watchlists of people on Stock Events who follow 8NN.F. It's not an investment recommendation.

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Intuitive Surgical
ISRG
Mkt Cap170.78B
Intuitive Surgical, Inc. designs, manufactures, and markets robotic products for minimally invasive surgery, indirectly competing with Thor Medical ASA by offering alternative cancer treatment solutions.
Medtronic
MDT
Mkt Cap106.97B
Medtronic plc offers medical technologies, including surgical solutions that may compete with Thor Medical ASA's cancer treatment technologies.
Boston Scientific
BSX
Mkt Cap92.25B
Boston Scientific Corporation develops, manufactures, and markets medical devices used in various interventional medical specialties, including oncology, potentially competing with Thor Medical ASA.
Zimmer Biomet
ZBH
Mkt Cap17.67B
Zimmer Biomet Holdings, Inc. provides musculoskeletal healthcare products and solutions, which may indirectly compete with Thor Medical ASA in the broader healthcare treatment market.
Stryker
SYK
Mkt Cap125.43B
Stryker Corporation specializes in medical technologies, including surgical equipment and neurotechnology products that could be used in cancer treatments, indirectly competing with Thor Medical ASA.
Abbvie
ABBV
Mkt Cap351.47B
AbbVie Inc. engages in the discovery, development, manufacture, and sale of a broad line of pharmaceuticals, including cancer treatments, directly competing with Thor Medical ASA.
Johnson & Johnson
JNJ
Mkt Cap547.64B
Johnson & Johnson engages in the research and development, manufacture and sale of a broad range of healthcare products, including cancer treatment solutions, making it a competitor to Thor Medical ASA.

About

Thor Medical ASA produces and supplies alpha-particle emitters for cancer therapy in Norway. It offers thorium-228, as well as radium-224 and lead-212 to radiopharmaceutical customers. The company was incorporated in 2009 and is headquartered in Oslo, Norway.
Show more...
CEO
Mr. Jasper Kurth
Employees
18
Country
Other
ISIN
NO0010597883
WKN
000A1H64K

Listings

0 Comments

Share your thoughts

FAQ

What is Thor Medical ASA stock price today?
The current price of 8NN.F is €0.43 EUR — it has increased by +0.23% in the past 24 hours. Watch Thor Medical ASA stock price performance more closely on the chart.
What is Thor Medical ASA stock ticker?
Depending on the exchange, the stock ticker may vary. For instance, on exchange Thor Medical ASA stocks are traded under the ticker 8NN.F.
Is Thor Medical ASA stock price growing?
8NN.F stock has fallen by -4.51% compared to the previous week, the month change is a +9.03% rise, over the last year Thor Medical ASA has showed a +122.82% increase.
What is Thor Medical ASA market cap?
Today Thor Medical ASA has the market capitalization of 151.63M
When is the next Thor Medical ASA earnings date?
Thor Medical ASA is going to release the next earnings report on August 28, 2026.
What is Thor Medical ASA revenue for the last year?
Thor Medical ASA revenue for the last year amounts to 0 EUR.
What is Thor Medical ASA net income for the last year?
8NN.F net income for the last year is -7.27M EUR.
How many employees does Thor Medical ASA have?
As of April 29, 2026, the company has 18 employees.
In which sector is Thor Medical ASA located?
Thor Medical ASA operates in the Health & Wellness sector.
When did Thor Medical ASA complete a stock split?
Thor Medical ASA has not had any recent stock splits.
Where is Thor Medical ASA headquartered?
Thor Medical ASA is headquartered in Oslo, Other.